International Study Shows Favorable 3-Year Results of 2 Glaukos iStent Trabecular Micro-Bypass Stents as Initial Treatment for Naive Glaucoma

News Newly diagnosed primary open-angle glaucoma patients who received 2 iStents achieved 43 percent reduction in mean intraocular pressure through 36 months following standalone surgery. Contributed Author:  Glaukos Corporation Topics:  Surgical